Medical Devices

Image

Global Patient Blood Management Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Report
  • Jul 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Patient Blood Management Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 12.07 Billion
Diagram Market Size (Forecast Year) USD 22.01 Billion
Diagram CAGR %

Global Patient Blood ManagementMarket, By Unit (Blood Components, Whole Blood), Articles (Instruments, Blood Processing Devices, Blood Transfusion Devices, Blood Culture Screening Devices, Diagnostic and Testing Instruments, Blood Storage Devices, Accessories, Syringes and Needles, Vials and Tubes, Blood Bank and Transfusion Software, Software, Assay Kits, Slide Staining, Blood Typing Reagents, Culture Media, Reagents and Kits, Blood Bags), End User (Hospitals, Blood Banks) – Industry Trends and Forecast to 2029

Patient Blood Management Market Analysis and Size

Better management results in patients typically needing fewer transfusions of donated blood components, preventing complications related to transfusions. The creation of patient blood management guidelines is being funded and overseen by the National Blood Authority. Patient blood management enhances patient outcomes by enhancing the patient's medical and surgical care in ways that support and conserve the patient's own blood.

Data Bridge Market Research analyses that the patient blood management market which was USD 12.07 billion in 2021, would rocket up to USD 22.01 billion by 2029, and is expected to undergo a CAGR of 7.80% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Patient Blood Management Market  Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Unit (Blood Components, Whole Blood), Articles (Instruments, Blood Processing Devices, Blood Transfusion Devices, Blood Culture Screening Devices, Diagnostic and Testing Instruments, Blood Storage Devices, Accessories, Syringes and Needles, Vials and Tubes, Blood Bank and Transfusion Software, Software, Assay Kits, Slide Staining, Blood Typing Reagents, Culture Media, Reagents and Kits, Blood Bags), End User (Hospitals, Blood Banks)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (U.S.), B Barun Melsungen AG (Germany), Maco Pharma (France), bioMérieux (France), KANEKA CORPORATION (Japan), Bio-Rad Laboratories Inc. (U.S.), Abbott (U.S.), Grifols, S.A. (Spain), F. Hoffmann-La Roche Ltd (Switzerland), LivaNova PLC (U.K.)

Market Opportunities

  • Rising demand for blood donations
  • Increase in the number of surgical procedures

Market Definition

In order to preserve haemoglobin concentration, maximise hemostasis, and reduce blood loss, patient blood management (PBM) is the timely use of evidence-based medical and surgical ideas.

Patient Blood Management Market Dynamics

Drivers

  • Increasing healthcare infrastructure

The patient blood management market is expected to experience dimensional growth from 2022 to 2029 due to the increased support for the value of donated blood from the various verticals of healthcare infrastructure, life sciences, placenta research, and haemoglobin for the advancement of the medical industry.

  • Rise in number of blood donors

The number of blood donors is increasing, and lucrative aid is being offered in exchange for donating blood. Due to the real-time solution offered, within this succession, the patient blood management market has moved toward the upside on the success graph due to the rapid increase of awareness given by mushrooming blood donation camps.

  • Technological developments

Accelerating pervasiveness of target viruses and forthcoming technological amendments is giving the optimum thrust in the market growth of the patient blood management market.

Opportunities

The possibility for market expansion will come from consumer familiarity with safe and secure blood donation transmission and usage and from market penetration in emerging markets.

Restraints/Challenges

Patient blood management businesses are subject to several restrictions during periods of rapid market growth, including costs associated with acquiring automated patient blood management systems and the potential for data loss. These concerns can limit the market's progress.

This patient blood management market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the patient blood management market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Patient Blood Management Market

The COVID-19 epidemic harmed the companies' sales. Lockdowns caused by the COVID-19 epidemic delayed people getting their health checked, reducing the number of tests performed and reagent sales. However, as governments gradually relax travel restrictions, testing numbers are increasing. Dealing with infectious diseases become major problem around the world since the COVID-19 pandemic. Aside from vaccines and therapeutic medications, there is a growing demand for more precise and simple testing technologies, as well as the expansion of testing structures.

Global Patient Blood Management Market Scope

The patient blood management market is segmented on the basis of articles, unit and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Unit

  • Blood Components
  • Whole Blood

 Articles

  • Instruments
  • Blood Processing Devices
  • Blood Transfusion Devices
  • Blood Culture Screening Devices
  • Diagnostic and Testing Instruments
  • Blood Storage Devices
  • Accessories
  • Syringes and Needles
  • Vials and Tubes
  • Blood Bank and Transfusion Software
  • Software
  • Assay Kits
  • Slide Staining
  • Blood Typing Reagents
  • Culture Media
  • Reagents and Kits
  • Blood Bags

 End User

  • Hospitals
  • Blood Banks

Patient Blood Management Market Regional Analysis/Insights

The patient blood management market is analysed and market size insights and trends are provided by country, articles, unit and end user as referenced above.

The countries covered in the patient blood management market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North america dominates the patient blood management market due to the eminent healthcare infrastructure.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period 2022 to 2029 due to the focus of various established market players to expand their presence in this particular region and encouraging repayment norms.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Patient Blood Management Market Share Analysis

The patient blood management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to patient blood management market.

Some of the major players operating in the patient blood management market are:

  • Haemonetics Corporation (U.S.)
  • Fresenius SE & Co. KGaA (Germany)
  • Terumo Corporation (Japan)
  • Immucor, Inc. (U.S.)
  •  B Barun Melsungen AG (Germany)
  •  Maco Pharma (France)
  • bioMérieux (France)
  • KANEKA CORPORATION (Japan)
  • Bio-Rad Laboratories Inc. (U.S.)
  • Abbott (U.S.)
  • Grifols, S.A. (Spain)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • LivaNova PLC (U.K.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The patient blood management market value is expected USD 22.01 billion by 2029.
The Patient Blood Management Market is to grow at a CAGR of 8.40% during the forecast by 2029.
The major players operating in the Patient Blood Management Market are Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (U.S.), B Barun Melsungen AG (Germany), Maco Pharma (France), bioMérieux (France), KANEKA CORPORATION (Japan), Bio-Rad Laboratories Inc. (U.S.), Abbott (U.S.), Grifols, S.A. (Spain), F. Hoffmann-La Roche Ltd (Switzerland), LivaNova PLC (U.K.).
The major countries covered in the Patient Blood Management Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials